Naphthyridine derivatives such as alpha V beta 6 integrin antagonists for the treatment of e.g. fibrotic diseases

• 收藏
• 分享

专利权人:

GlaxoSmithKline Intellectual Property Development Limited

发明人:

ANDERSON, Niall Andrew,CAMPBELL-CRAWFORD, Matthew Howard James,HANCOCK, Ashley Paul,PRITCHARD, John Martin,REDMOND, Joanna Mary

申请号：

DK15767475

公开号：

DK3197892T3

申请日:

2015.09.22

申请国别(地区):

DK

年份:

2018

代理人:

摘要：

A compound of formula (I): being 4-(3-Fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy) phenyl) butanoic acid, or a salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/